Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a leading contributor to mortality during recent influenza pandemics. The mechanism for this influenza-induced susceptibility to secondary S. aureus infection is poorly understood. In this study, we show that innate antibacterial immunity was significantly suppressed during the recovery stage of influenza infection, even though MRSA superinfection had no significant effect on viral burdens. Compared with mice infected with bacteria alone, postinfluenza MRSA-infected mice exhibited impaired bacterial clearance, which was not due to defective phagocyte recruitment, but rather coincided with reduced intracellular reactive oxygen species levels in alveolar macrophages and neutrophils. NADPH oxidase is responsible for reactive oxygen species production during phagocytic bacterial killing, a process also known as oxidative burst. We found that gp91 phox -containing NADPH oxidase activity in macrophages and neutrophils was essential for optimal bacterial clearance during respiratory MRSA infections. In contrast to wild-type animals, gp91 phox2/2 mice exhibited similar defects in MRSA clearance before and after influenza infection. Using gp91 phox+/2 mosaic mice, we further demonstrate that influenza infection inhibits a cell-intrinsic contribution of NADPH oxidase to phagocyte bactericidal activity. Taken together, our results establish that influenza infection suppresses NADPH oxidase-dependent bacterial clearance and leads to susceptibility to secondary MRSA infection. The Journal of Immunology, 2014, 192: 3301-3307. V iral influenza is often a seasonal infection that can lead to primary influenza pneumonia. However, secondary bacterial infections, commonly associated with Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae, are known to be more frequent causes of severe morbidity and mortality (1) . Among these, methicillin-resistant S. aureus (MRSA) has emerged as the leading contributor to mortality during recent influenza pandemics and epidemics (2) (3) (4) (5) (6) (7) . A dysregulated immune defense against either influenza virus or S. aureus has been proposed as a contributor to coinfection pathogenesis (8) (9) (10) (11) ; however, an incomplete understanding of coinfection pathophysiology has slowed the development of effective treatments (12) (13) (14) .
NADPH oxidase produces superoxide, which can spontaneously form hydrogen peroxide that will undergo further reactions to generate reactive oxygen species (ROS). During influenza virus infection alone, gp91
phox -containing NADPH oxidase has been shown to exacerbate lung inflammation (15) (16) (17) (18) , even though there is no evidence linking its detrimental effect to enhanced enzymatic activity. In contrast, during S. aureus lung infection alone, phagocyte ROS generation is essential for antibacterial immunity (19, 20) . However, the outcome of these conflicting contributions of NADPH oxidase to immune defense against influenza and S. aureus coinfection has not been addressed in any reported studies. Instead, several reports have demonstrated that synergistic influenza and S. aureus coinfection is associated with dysregulation of antibacterial immunity (8) (9) (10) (11) . Therefore, we sought to determine the regulatory effect of influenza infection on ROS-dependent antibacterial activity and its contribution to susceptibility to subsequent S. aureus infection. In our model, we found that innate antibacterial immunity was significantly suppressed following influenza infection. In addition, mice were more susceptible to respiratory MRSA infection in the absence of NADPH oxidase activity. Importantly, we show that influenza infection inhibited the cell-intrinsic contribution of NADPH oxidase to phagocytic bacterial killing, which led to susceptibility to secondary MRSA infection.
Materials and Methods

Murine model of viral and bacterial infection
Specific pathogen-free, C57BL/6 wild-type (WT), gp91
2/2 , and "Mafia" mice were initially purchased from The Jackson Laboratory (Bar Harbor, ME) and bred at Albany Medical College following Institutional Animal Care and Use Committee guidelines.
Viral challenge was performed with A/PR/8 or H1N1 CA4 administered intranasally (i.n.) to anesthetized and sex-and age-matched adult mice in 50 ml sterile PBS. Unless otherwise specified, bacterial coinfection was performed at 7 d after influenza infection. To induce bacterial pneumonia, anesthetized mice were inoculated i.n. with 50 patient sputum) or MRSA BAA-1692 (an isolate from human sinus) obtained from the American Type Culture Collection. Titers of virus stocks and viral levels in the bronchoalveolar lavage fluids (BALF) and lungs of infected mice were determined by plaque assays on MDCK cell monolayers (21) . Bacterial burdens in the lungs and BALF were measured by sacrificing infected mice at the indicated time points and plating serial 10-fold dilutions of each sample onto blood agar plates.
Bronchoalveolar lavage cell analysis
Bronchoalveolar lavage (BAL) was collected by making an incision in the trachea and gavaging the lung twice with 0.8 ml PBS (pH 7.4). The BAL cells were incubated with 2.4G2 mAb against FcgRII/III and stained with PEor allophycocyanin-conjugated anti-CD11c (Caltag Laboratories, Burlingame, CA), FITC-or PE-Cy7-conjugated anti-CD11b (BD Biosciences), FITCor PE-conjugated anti-Ly6G mAb (clone 1A8; BD Biosciences), and APCCy7-conjugated anti-Ly6C mAb (BD Biosciences). The stained cells were analyzed on a BD FACSCanto using BD FACSDiva software.
Detection of gp91 phox WT and deficient neutrophils gp91 phox expression in neutrophils was assessed with an anti-mouse gp91 phox mAb (BD Biosciences) (22) . Briefly, after staining for neutrophils with FITC-conjugated anti-mouse Ly6G mAb and PE-Cy7-conjugated anti-mouse CD11b mAb, cells in suspension were fixed with 2% paraformaldehyde for 20 min. Cells were then washed with PBS and permeabilized with BD Perm Buffer IV for 20 min. Cells were washed twice with 2% BSA in PBS and then incubated with purified mouse antigp91 phox mAb for 30 min. Cells were washed and incubated with PEconjugated rat anti-mouse IgG1 Ab (BD Biosciences) prior to analysis by flow cytometry.
Flow cytometry analysis of oxidative stress in BALF cells
Seven days after i.n. inoculation of 50 PFU PR8 influenza virus, mice were infected i.n. with 10 7 CFU MRSA, and 24 h later, BALF cells were collected and incubated with CellROX Deep Red reagent (Invitrogen) at a final concentration of 5 mM in complete RPMI 1640 medium for 30 min at 37˚C, washed three times with PBS, and then fixed with 3.5% formaldehyde for 15 min before staining for surface marker expression (Supplemental Fig. 1 ). BALF cells incubated with RPMI 1640 medium alone were used for background staining of individual cell subsets.
Neutrophil depletion during MRSA infection
Anti-Gr-1 mAb was purified from culture supernatants of the RB6-8C5 hybridoma using anti-rat IgG-agarose columns (Sigma-Aldrich, St. Louis, MO). For neutrophil depletion, mice were injected i.p. 48 and 24 h before bacterial infection with 0.1 mg RB6-8C5 anti-Gr-1 mAb or with rat IgG as a control. The efficiency and specificity of neutrophil depletion in BALF of MRSA-infected mice was confirmed by flow cytometry analysis (Supplemental Fig. 2 ).
Alveolar macrophage depletion during MRSA infection
Mafia transgenic mice have an inducible Fas suicide/apoptotic system driven by the mouse colony stimulating factor-1 receptor promoter (23) . The transgene insert contains a mutant human FK506 binding protein 1A, which preferentially binds the dimerization drug AP20187. Administration of AP20187 induces apoptosis specifically in macrophages and dendritic cells.
AP20187 was a gift from Ariad Pharmaceuticals. Lyophilized AP20187 was dissolved in 100% ethanol at a concentration of 13.75 mg/ml. A working solution for peritoneal injections was prepared from the stock diluted to 0.55 mg/ml in 4% ethanol, 10% polyethylene glycol-400, and 1.7% Tween 20. Mafia mice were injected i.p. for 5 consecutive days with 300 ml AP20187 or diluent control. The mice were then rested for another 6 d before i.n. infection with S. aureus. The efficiency of pulmonary macrophage depletion was confirmed by flow cytometry (24) .
Statistical analyses
Results are expressed as means 6 SD. Significant differences between experimental groups were determined using a Student t test (to compare two samples) or an ANOVA analysis, followed by Tukey's multiple comparisons test (to compare multiple samples) in GraphPad Prism 6 (La Jolla, CA). Survival analyses were performed using the Kaplan-Meier logrank test. For all analyses, p , 0.05 was considered to be significant.
Results
Influenza infection impairs innate defense against a subsequent S. aureus respiratory challenge
To establish a mouse model that mimics the clinical observation that influenza infection predisposes individuals to S. aureus infection, we followed an experimental protocol similar to our previous secondary pneumococcal infection studies (25, 26) . Specifically, C57BL/6 mice were infected with a sublethal dose of H1N1 CA04 influenza virus and followed by i.n. challenge with 10 7 CFU MRSA BAA-1692 at days 5, 7, or 9 after viral infection. Coinfected mice were sacrificed 24 h after MRSA infection (i.e., days 6, 8, and 10 postinfluenza infection) for determination of lung viral and bacterial burdens. Compared with animals infected with MRSA only, influenza and MRSA-coinfected mice exhibited decreased ability to clear bacteria from their lungs (Fig. 1A) . However, the relative defect in bacterial clearance was significantly exacerbated in mice superinfected with MRSA at day 7 postinfluenza as compared with day 5 superinfected animals (Fig. 1B) , indicating greater susceptibility to secondary S. aureus infection at the beginning of the viral recovery phase (Fig. 1C) .
To determine the possible strain-specific effect of influenza virus or S. aureus on coinfection outcomes, mice were next infected with PR8 virus and superinfected with the community-acquired MRSA strain BAA-1695 on day 7 postinfluenza. Consistent with the observations above, bacterial burdens were significantly increased in PR8-infected mice ( Fig. 2A) . Interestingly, MRSA superinfection did not appear to affect viral loads in the lung (Fig. 2B ). Accordingly, coinfection was associated a high mortality rate (.90%), after an increased (2 3 10 8 CFU) MRSA challenge dose, which was not observed with either infectious agent alone (Fig. 2C) . Collectively, these results indicate that anti-MRSA immunity is profoundly inhibited at the recovery stage of influenza infection, which is correlated with a lethal outcome following influenza and S. aureus coinfection. 
Influenza infection inhibits phagocyte antibacterial function in the airways
To determine how influenza infection leads to defective bacterial clearance, we next examined airway phagocyte recruitment after influenza and/or MRSA infection. On the basis of the published reports (27, 28) , alveolar macrophages were defined as CD11c ) recruitment into the respiratory tract (Fig. 3A) . However, comparable numbers of neutrophils were detected in MRSA-infected and coinfected mice, which were higher than neutrophil counts in mice infected with influenza alone. In fact, there were increased total numbers of phagocytes in coinfected mice because of the recruitment of inflammatory monocytes (CD11b
) following influenza infection. On the basis of this observation, we hypothesized that the antibacterial function of these phagocytes is impaired, which then leads to defective bacterial clearance in coinfected mice.
Given the critical role of NADPH oxidase in innate defense against S. aureus lung infection, we next determined whether phagocyte oxidative burst was impaired following influenza infection. Significantly decreased ROS levels were observed in alveolar macrophages (CD11c (Fig. 3B, Supplemental Fig. 1 ). It is noteworthy that alveolar macrophages from normal mice exhibited increased ROS mean fluorescence intensity compared with neutrophils, which was not necessarily due to their greater ROS-generating capacity, but rather, their higher autofluorescence (29) . This result suggests that influenza infection impairs the ability of alveolar macrophages and neutrophils to mediate ROS-dependent bactericidal function.
Influenza infection suppresses NADPH oxidase-dependent phagocytic bacterial killing
We next assessed the possible innate immune components involved in pulmonary S. aureus killing without influenza infection, because influenza-induced susceptibility to MRSA infection is essentially a result of the negative regulation of these antibacterial factors. NADPH oxidase is responsible for ROS production during phagocytic killing of S. aureus (30), and both gp91 phox and p47 phox are critical subunits for enzyme activity. Consistent with findings from other in vivo S. aureus infection studies (19, 20) , we showed that NADPH oxidase was necessary for optimal killing of S. aureus using in the current model, as demonstrated by significantly increased lung bacterial burdens in gp91 phox2/2 and p47
, but not NOS2 2/2 mice (Fig. 4A ).
In contrast, previous reports suggest that innate clearance of S. aureus only requires neutrophils but not macrophages (20, 31, 32) . gp91
phox is the specific catalytic subunit of NADPH oxidase in phagocytes, including both macrophages and neutrophils. Our results above demonstrated that influenza infection reduces ROS levels in alveolar macrophages. To provide direct evidence that macrophages and their oxidative burst are essential for pulmonary clearance of S. aureus, we compared bacterial burdens in neutrophil-depleted WT and gp91 phox2/2 mice. Pulmonary MRSA burdens were significantly increased after neutrophil depletion (Fig. 4B) . Interestingly, there was a significant difference in bacterial burdens between neutrophil-depleted gp91 phox2/2 and neutrophil-depleted WT mice (Fig. 4B) , suggesting an important contribution of macrophages to NADPH oxidase-dependent control of bacterial outgrowth. Consistent with this, increased bacterial burdens were found in macrophage-depleted Mafia mice (Fig. 4C) . The essential role of neutrophils in host defense against pulmonary MRSA infection was revealed by increased mortality rates in neutrophil-depleted mice (Fig. 4D) . Prolonged macrophage depletion compromises the health of Mafia mice (23); therefore, it was not feasible to directly evaluate the contribution of macrophages to survival from MRSA infection. Nonetheless, the highly elevated bacterial counts in neutrophil-depleted gp91 phox2/2 mice were accompanied by increased mortality after a relatively low-dose (1 3 10 7 CFU) MRSA infection (Fig. 4E) . Taken together, these results indicate that neutrophils, macrophages, and their associated NADPH oxidase are essential for efficient pulmonary MRSA containment.
To determine the possible effect of influenza infection on ROSdependent bacterial clearance, we next examined anti-MRSA immunity in influenza-infected gp91 phox2/2 mice. We hypothesized that if influenza infection impaired anti-MRSA immune mechanisms other than NADPH oxidase-mediated bacterial killing, coinfected gp91 phox2/2 mice should have further increased bacterial burdens as compared with MRSA-infected gp91 phox2/2 animals. On the contrary, we found that gp91 phox2/2 mice exhibited similar defects in MRSA clearance both before and after influenza infection, whereas WT mice were defective only after influenza infection (Fig. 5A ). This indicates that influenza infection predominantly inhibits NADPH oxidase-dependent MRSA clearance. In addition, BALF cytology revealed an increase in neutrophil counts in the coinfected gp91 phox2/2 mice relative to coinfected WT mice (Fig. 5B) . However, in the absence of downstream effector NADPH oxidase, this enhanced antibacterial immune response failed to facilitate bacterial clearance in coinfected gp91 phox2/2 mice (Fig. 5A) . These results further established that susceptibility to postinfluenza MRSA is due to defective phagocyte antibacterial function. Interestingly, influenza infection resulted in defective bacterial clearance in NOS2 2/2 mice in a pattern similar to WT mice (data not shown), even though NOS2 also participates in phagocyte oxidative burst. Despite of its detrimental effect on lung inflammation (15) (16) (17) (18) , an overall impact of NADPH oxidase on animal mortality was not evident after a lethal dose of influenza infection alone (Fig. 6A) . Conversely, both p47 phox2/2 and gp91 phox2/2 mice exhibited increased susceptibility to S. aureus infection alone compared with WT mice (Fig. 6B) . Furthermore, gp91 phox2/2 mice were highly susceptible to postinfluenza bacterial infection, as revealed by rapid mortality kinetics and decreased survival rates compared with WT animals (Fig. 6C, 6D, respectively) . These data suggest that NADPH oxidase-dependent anti-MRSA immunity is impaired, although not absolutely absent, in coinfected WT mice.
The cell-intrinsic contribution of NADPH oxidase to the immune defense against postinfluenza MRSA infection
The data above demonstrate that influenza infection inhibits NADPH oxidase-dependent bacterial clearance and predisposes mice to secondary MRSA infection. Conversely, it has been reported that gp91 phox -containing NADPH oxidase promotes influenza infectionassociated immunopathology to surrounding tissues, because of the nonspecific toxic effect of extracellular ROS (15) (16) (17) (18) . To differentiate these concomitant but conflicting contributions of NADPH oxidase, we next sought to determine whether influenza infection impairs the cell-intrinsic contribution of NADPH oxidase to phagocytic bacterial killing. The gp91 phox subunit is an X chromosome-linked gene.
Female gp91
phox+/2 (mosaic) mice have both gp91 phox WT and deficient circulating neutrophils because of random inactivation of the X chromosome in individual cells (Fig. 7A) . Therefore, the potential cell-intrinsic NADPH oxidase-dependent phagocytic killing could be determined in such mosaic animals. Influenza infection induced an increase in the percentage of blood neutrophils in gp91 phox mosaic mice (Fig. 7A, 7B ). However, a similar ratio of gp91 phox WT and deficient blood neutrophils was detected in mosaic mice before and after influenza infection, which was also comparable to that in airways after influenza infection (Fig. 7B ). These observations suggest that gp91
phox WT and deficient neutrophil subpopulations in mosaic mice perform similarly in terms of differentiation and migration. Conversely, despite the abundance of gp91 phox WT neutrophils in mosaic mice, their lung bacterial burdens were greatly increased compared with WT mice after MRSA infection (Fig. 7C) . Moreover, similar to gp91 phox2/2 mice, mosaic mice exhibited defective MRSA clearance both before and after influenza infection (Fig. 7C) . Taken together, these results further demonstrated that influenza infection suppresses cell-intrinsic contributions of NADPH oxidase to phagocytic bacterial killing.
Discussion
In the current study, we demonstrated that influenza and MRSA coinfection is associated with defective antibacterial immunity. , and p47 phox2/2 mice (A), a-PMN Ab-treated WT and gp91 phox2/2 mice (B), and Mafia mice (C). In (B), mice were treated with RB6-8C5 mAb for neutrophil depletion. In (C), Mafia mice were depleted of macrophages using AP20187 dissolved in ethanol. Control WT mice were also treated with AP20187. ( Compared with mice challenged with bacteria alone, postinfluenza MRSA-infected animals were characterized by significantly increased bacterial burdens, increased numbers of inflammatory monocytes, reduced ROS levels in alveolar macrophages and neutrophils in the airways. At the same time, no significant effect of MRSA superinfection on antiviral immunity was observed. Furthermore, gp91 phox2/2 phagocytes were defective in their antibacterial function. This cell-intrinsic contribution of NADPH oxidase activity to phagocytic bacterial killing was established using mosaic mice containing both NADPH oxidase WT and deficient phagocyte subpopulations. Importantly, similar to gp91 phox2/2 mice, these mosaic mice exhibited similar defective MRSA clearance both before and after influenza infection. Collectively, the results presented in this study demonstrate that influenza virus infection suppresses NADPH oxidase-dependent phagocytic bacterial clearance and leads to susceptibility to secondary MRSA infection.
Multiple mechanisms have been implicated in the adverse outcome of influenza and bacterial coinfection, namely: 1) direct viral cytotoxicity associated with increased viral burden (8, 10); 2) cytotoxicity as a result of bacterial outgrowth (9, 10, 33-37); and 3) inflammatory tissue damage because of excessive production of proinflammatory mediators and defective resolution/tissue repair responses (38) (39) (40) . The observed differences in the relative contributions of virus, bacteria, and host inflammation to the pathogenesis of coinfection primarily reflect variation in the timing of bacterial inoculation in these experimental models. When mice were infected with MRSA at the beginning of the viral recovery phase, we found that coinfection-induced high mortality rates that were associated with impaired antibacterial immunity and excessive inflammatory infiltrates but not exacerbated viral infection. These effects were observed with both PR8 and H1N1 CA04 influenza virus infection (25, 26) .
In recent studies, impaired antibacterial immunity has been shown to be associated with dysregulated pulmonary cytokine responses following influenza infection. Small et al. (9) reported that influenza infection impairs TNF-a production and causes increased susceptibility to subsequent S. aureus infection. It has also been reported that influenza A inhibits IL-1b and Th17-mediated host defense against S. aureus pneumonia in mice, although the molecular mechanisms involved remain elusive (11, 33) . Whereas those studies described an association between suppression of proinflammatory responses and defective bacterial clearance during influenza infection, how decreased cytokine responses lead to defective antibacterial immunity remains unclear. Nonetheless, it has been show that TNF-a and IL-1b prime the respiratory burst in phagocytes (41, 42) , and their reduced production in influenzainfected mice might be responsible for decreased ROS. Our previous work with secondary pneumococcal infection demonstrated that IFN-g is responsible for inhibition of innate bacterial clearance (25) . The dynamics of susceptibility to postinfluenza MRSA infection resemble those of postinfluenza pneumococcal infection. Moreover, an in vitro study suggests that IFN-g can inhibit macrophage-mediated phagocytosis of S. aureus (43) . Conversely, it is shown that T cell-derived IFN-g can actually perpetuate infection in a S. aureus wound infection model by increasing neutrophil recruitment, cells that can serve a reservoir for bacterial growth (44) . Therefore, IFN-g might have a different effect on phagocyte-mediated clearance of S. aureus versus pneumococci. This differential regulatory role may be related to differences in the effector mechanisms that are needed to eliminate these two pathogens. For example, a macrophage receptor with collagenous structure is critical for alveolar macrophage-mediated clearance of pneumococci but not S. aureus clearance (K. Sun, unpublished observations). Conversely, NADPH oxidase activity, which is likely to overcome the antioxidant action of endogenous staphylococcal catalase, is essential for pulmonary S. aureus clearance but is dispensable for pneumococcal eradiation (24) .
There is controversy surrounding the relative contribution of macrophages to pulmonary clearance of S. aureus (20, 31, 32) . However, we found that the immunological killing of S. aureus requires both neutrophils and macrophages. NADPH oxidase also has been found to be important for antibacterial immunity (20) . Consistent with this, we observed increased bacterial loads and mortality after MRSA infection of NADPH oxidase-deficient mice. Because 98% of leukocytes in the airways of MRSA-infected mice were composed of alveolar macrophages and neutrophils (Fig. 3A,  Supplemental Fig. 1 ), the lack of control of MRSA infection observed in gp91 phox2/2 mice is likely due to defective oxidasedependent bacterial killing by these phagocytes. In postinfluenza MRSA-infected mice, analysis of myeloid cell profiles in the airway revealed accumulation of neutrophils and inflammatory monocytes, suggesting that the defective antibacterial immunity in these mice was not associated with total numbers of phagocytes but rather their reduced antimicrobial ability. It is noteworthy that in contrast to our observations in animal models, in vitro coculture of influenza A virus/S. pneumonia with neutrophils increased the respiratory burst activity of these host cells (45) , probably because pneumolysin released by S. pneumonia is a potent activator of intracellular oxygen radical production (46) . Nonetheless, unlike S. aureus, NADPH oxidase is not essential for phagocytic killing of S. pneumonia (24, 47) . In fact, gp91
phox2/2 mice demonstrate increased resistance to pneumococcal infection compared with WT controls (48) . Nonetheless, we found that influenza infection impaired ROS generation in both alveolar macrophages and neutrophils, which, together with the observation that similar defective bacterial clearance was detected in gp91
phox -deficient and mosaic mice with or without influenza infection, suggests that NADPH oxidase-dependent bacterial killing is the principal pathway by which influenza infection regulates innate antibacterial immunity.
Although phagocyte NADPH oxidase is critical for host antibacterial immunity, it also has been shown to promote detrimental inflammatory responses during influenza infection (15) (16) (17) (18) . As such, alleviated lung pathologies and reduced accumulation of airway inflammatory cells were detected in NADPH oxidase-deficient mice in response to inactivated H5N1 avian influenza virus (18) or early after low pathogenicity H3N2 influenza infection (15) . Therefore, the negative regulation of phagocyte ROS generation at the recovery stage of influenza infection, as revealed in the current study, has likely evolved to minimize influenza infection-associated lung damage. In agreement with our findings, it has been shown that both basal and phorbol dibutyrate-stimulated superoxide production in airway inflammatory cells are decreased from days 3 to 7 after influenza infection, which is associated with a suppressive effect of Nox1 oxidase in tissue cells (49) . Considering that gp91 phox -dependent generation of superoxide is not absent, but rather reduced in influenza-infected WT mice, it is not surprising that gp91 phox2/2 mice exhibit attenuated lung inflammatory damage compared with WT controls and inhibition of NADPH oxidase reduces disease severity during influenza infection alone (i.e., in the absence of secondary S. aureus infection) (15) (16) (17) .
The present studies were conducted using a mouse infection model, which is well accepted for studying influenza and influenzacompromised bacterial infection (50) . However, mice are not only highly resistant to S. aureus infection but also exhibit very rapid mortality kinetics after a lethal inoculum. To minimize complications from compensatory or secondary inflammatory responses because of lethal bacterial burdens, we infected mice with a relatively low dose of MRSA to examine the influence of influenza infection on protective antibacterial immunity and then confirmed these findings with higher inoculums for survival studies. The results of this study establish for the first time, to our knowledge, that influenza infection suppresses cell-intrinsic contribution of NADPH oxidase to phagocytic bacterial killing, and predisposes hosts to secondary S. aureus infection.
